Kyverna Therapeutics, Inc. KYTX
NASDAQ · United States · Health Technology
$6.22-0.30 (-4.60%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.63 | -0.68 | +7.1% | $0 | — | +2.0%$7.89→$8.05 |
| Q1 2026 | 2026-05-12 | -0.66 | -0.75 | +12.0% | — | — | +4.3%$10.34→$10.78 |
| Q4 2025 | 2026-03-26 | -0.80 | -0.86 | +7.0% | — | — | -0.9%$7.87→$7.80 |
| Q3 2025 | 2025-11-12 | -0.85 | -0.95 | +10.5% | — | — | -7.4%$7.00→$6.48 |
| Q2 2025 | 2025-08-12 | -0.97 | -1.04 | +6.7% | — | — | — |
| Q1 2025 | 2025-05-13 | -1.03 | -1.00 | -3.0% | — | — | — |
| Q4 2024 | 2025-03-27 | -0.88 | -0.82 | -7.3% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.80 | -0.80 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.